Detalhe da pesquisa
1.
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
Leukemia
; 31(11): 2398-2406, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28804124
2.
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV.
Leukemia
; 29(5): 1123-32, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25676422